跳转至内容
Merck
CN

SML2896

Sigma-Aldrich

ONO-2506

≥98% (HPLC)

别名:

(-)-(2R)-2-Propyloctanoic acid, (2R)-2-Propyloctanoic acid, (R)-(-)-2-Propyloctanoic acid, (R)-2-Propyloctanoic acid, Arundic acid, ONO 2506, ONO2506

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C11H22O2
化学文摘社编号:
分子量:
186.29
MDL编号:
UNSPSC代码:
12352200
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

方案

≥98% (HPLC)

表单

oil

颜色

colorless to yellow

储存温度

−20°C

SMILES字符串

OC(=O)[C@@H](CCCCCC)CCC

InChI

1S/C11H22O2/c1-3-5-6-7-9-10(8-4-2)11(12)13/h10H,3-9H2,1-2H3,(H,12,13)/t10-/m1/s1

InChI key

YCYMCMYLORLIJX-SNVBAGLBSA-N

生化/生理作用

Inhibitory astrocytes-modulating agent that exerts glioprotective effects in cultures and in vivo by decreasing intracellular and extracellular S100B levels.
ONO-2506 (arundic acid; (R)-2-propyloctanoic acid) is an inhibitory astrocytes-modulating agent that exerts glioprotective effects against amyloid-β-peptide (Aβ)-induced glial death in astrocyte cultures (50 μM ONO-2506 against 200 μM Aβ25-35, 24 hr; 1321N1 astrocytes) by decreasing both the intracellular and extracellular S100B levels. Blockade of astrocytic activation by ONO-2506 in vivo is shown to offer therapeutic efficacy in animal models of normal tension glaucoma (10 mg/kg po. mice), spinal cord injury (20 mg/kg/d ip or iv rats), brain seizure, ischemic stroke (10 mg/kg/d ip or iv rats), and Parkinson′s disease (30 mg/kg ip mice).

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

C Mari et al.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 76, 41-51 (2019-06-17)
Perinatal hypoxia-ischemia (HI) is one of the main causes of mortality and chronic neurological morbidity in infants and children. Astrocytes play a key role in HI progression, becoming reactive in response to the injury, releasing S100 calcium binding protein B
Narito Tateishi et al.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 22(6), 723-734 (2002-06-05)
A novel agent, (R)-(-)-2-propyloctanoic acid (ONO-2506), has a unique property in that it modulates functions of activated cultured astrocytes, including pronounced inhibition of S-100beta synthesis. The present study examined whether administration of this agent would mitigate the delayed expansion of
Isato Fukushi et al.
Respiratory physiology & neurobiology, 226, 24-29 (2015-11-26)
Mild hypoxia increases ventilation, but severe hypoxia depresses it. The mechanism of hypoxic ventilatory depression, in particular, the functional role of the cerebrum, is not fully understood. Recent progress in glial physiology has provided evidence that astrocytes play active roles
Mojtaba Keshavarz et al.
Iranian journal of basic medical sciences, 22(5), 557-562 (2019-06-21)
Valproic and arundic acids are astrocytes-modulating agents with potential effects in the treatment of Alzheimer's disease (AD). S100B is an astrocytic cytokine with a possible role in the pathogenesis of AD. In this study, we aimed to assess the glioprotective
Mitsuru Hanada et al.
Journal of the neurological sciences, 337(1-2), 186-192 (2013-12-24)
Arundic acid (ONO-2506) inhibits the production and release of S100 protein from astrocytes. While numerous studies have assessed the effect of ONO-2506 in the diseased brain, to the best of our knowledge, no study has examined the effect of ONO-2506

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持